Alzheimer's Disease Screening in Home Health Agencies
GIA® calls patients by landline or video between home health visits — providing continuous screening that visiting clinicians cannot. Changes in speech patterns between Tuesday’s visit and Thursday’s call are detected automatically.
Why Alzheimer's Disease goes undetected in home health agencies
Visiting nurses and therapists manage caseloads of 5-7 patients per day. Visit time is consumed by the primary reason for service. Screening for comorbid conditions is aspirational, not practical. Alzheimer's Disease symptoms are often subtle, progressive, and easily attributed to other factors in this care environment.
Clinicians see patients for 30-60 minutes, 1-3 times per week — conditions change between visits
Cognitive and behavioral health screening is rarely prioritized during home visits focused on wound care, medication management, or physical therapy
No continuous monitoring capability between visits
Readmission penalties under HHVBP make missed conditions financially costly
How does GIA® screen for Alzheimer's Disease in home health agencies?
GIA® meets the patient by video, voice, or landline — wherever they are in the home health agencie environment. The screening conversation takes under five minutes and feels like a natural check-in, not a clinical assessment.
During the conversation, GIA® analyzes over 2,500 speech biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load indicators — alongside 436 visual data points from facial micro-expressions and body movement during video sessions.
Results are delivered to the clinician in 60 seconds. Four data types write back to the EHR automatically: structured screening results with ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video. The clinician reviews and submits — the human is always in the loop.
What compliance requirements does this address?
OASIS assessments require cognitive and behavioral health documentation. HHVBP ties reimbursement to outcomes including hospital readmission rates.
GIA® produces survey-ready documentation automatically — structured screening results, medical notes, full transcripts, and patient video — all written back to the EHR in real time. When a surveyor asks how you screen for alzheimer's disease, the answer is in the patient record: timestamped, structured, and reviewable.
Alzheimer's Disease screening in home health agencies
How is Alzheimer's Disease screened in home health agencies?
GIA® screens for Alzheimer's Disease through a single conversational interaction lasting under 5 minutes. She analyzes over 2,500 speech biomarkers using Voice AI, Computer Vision, and Speech Biomarkers. GIA® calls patients by landline or video between home health visits — providing continuous screening that visiting clinicians cannot. Changes in speech patterns between Tuesday’s visit and Thursday’s call are detected automatically. Results are delivered to the clinician in 60 seconds.
Does Alzheimer's Disease screening require additional staff?
No. GIA® conducts the screening conversation independently — zero additional clinical staff required during the interaction. Visiting nurses and therapists manage caseloads of 5-7 patients per day. Visit time is consumed by the primary reason for service. Screening for comorbid conditions is aspirational, not practical. The clinician reviews the results in under 2 minutes.
What is the accuracy of Alzheimer's Disease screening?
Alzheimer's Disease screening accuracy: Clinically validated vocal biomarker screening. The platform is 510(k) registered and trained on 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events.
Alzheimer's Disease screening in other care settings
Other conditions screened in home health agencies
See GIA® screen for Alzheimer's Disease live
Under 5 minutes. 60-second results. Zero staff time.